...
首页> 外文期刊>Cancer Cell >Protein Kinase C iota Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma
【24h】

Protein Kinase C iota Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma

机译:蛋白激酶C IOTA在突变体KRAS肺腺癌中驱动Notch3依赖性干燥表型

获取原文
获取原文并翻译 | 示例
           

摘要

We report that the protein kinase C iota (PKC iota) oncogene controls expression of NOTCH3, a key driver of stemness, in KRAS-mediated lung adenocarcinoma (LADC). PKC iota activates NOTCH3 expression by phosphorylating the ELF3 transcription factor and driving ELF3 occupancy on the NOTCH3 promoter. PKC iota-ELF3-NOTCH3 signaling controls the tumor-initiating cell phenotype by regulating asymmetric cell division, a process necessary for tumor initiation and maintenance. Primary LADC tumors exhibit PKC iota-ELF3-NOTCH3 signaling, and combined pharmacologic blockade of PKC iota and NOTCH synergistically inhibits tumorigenic behavior in vitro and LADC growth in vivo demonstrating the therapeutic potential of PKC iota-ELF3-NOTCH3 signal inhibition to more effectively treat KRAS LADC.
机译:我们认为蛋白激酶C IOTA(PKC IOTA)癌基因对kRas介导的肺腺癌(LADC)中的Notch3,茎的关键驱动器的表达。 PKC IOTA通过磷酸化ELF3转录因子并在Notch3启动子上驾驶ELF3占用来激活Notch3表达。 PKC IOTA-ELF3-NOTCH3信号传导通过调节不对称细胞分裂来控制肿瘤起始细胞表型,该方法是肿瘤起始和维护所需的方法。 主要LADC肿瘤表现出PKC IOTA-ELF3-NOTCH3信号传导,PKC IOTA和NOTCH的组合药理学阻滞协同抑制体外致致瘤性行为和LADC生长的体内,证明了PKC IOTA-ELF3-Notch3信号抑制的治疗潜力更有效地治疗KRA Ladc。

著录项

  • 来源
    《Cancer Cell》 |2016年第3期|共12页
  • 作者单位

    Mayo Clin Ctr Canc Dept Canc Biol Jacksonville FL 32224 USA;

    Mayo Clin Ctr Canc Dept Canc Biol Jacksonville FL 32224 USA;

    Mayo Clin Ctr Canc Dept Canc Biol Jacksonville FL 32224 USA;

    Mayo Clin Ctr Canc Dept Canc Biol Jacksonville FL 32224 USA;

    Mayo Clin Ctr Canc Dept Canc Biol Jacksonville FL 32224 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号